脑小血管病性认知功能障碍的危险因素研究进展
Research Progress in Risk Factors for Cognitive Dysfunction in Cerebral Small Vessel Disease
DOI: 10.12677/ACM.2022.12121623, PDF,   
作者: 宋芳星, 周慧敏:济宁医学院临床医学院,山东 济宁;韩士军:临清市人民医院神经外科,山东 聊城;王婧彬:高唐县人民医院神经内科,山东 聊城;闫中瑞*:济宁市第一人民医院神经内科,山东 济宁
关键词: 脑小血管病认知功能障碍危险因素研究进展Cerebral Small Vessel Disease Cognitive Dysfunction Risk Factors Research Progress
摘要: 脑小血管病(cerebral small vessel disease, CSVD)是一组具有不同病理背景的各种血管疾病。脑血管的高级脉管系统网通常受到影响,包括小动脉、微动脉、毛细血管、微静脉和小静脉。脑小血管疾病有几种分类:其中包括Binswanger病、脑白质疏松症、脑微出血(CMBs)和腔隙性中风等疾病,临床表现为认知功能下降、情感障碍等。脑小血管病性认知功能障碍是血管性认知障碍的重要亚型,且认知功能障碍是脑小血管病最常见的临床表现。脑小血管病诱发认知功能障碍的危险因素可能涉及年龄、性别、肥胖等因素,因此对脑小血管病性认知功能障碍的危险因素进行深入探讨,可进一步提升和丰富脑小血管病性认知功能障碍的防治,延缓疾病进展,提高生活质量。
Abstract: Cerebral small vessel disease (CSVD) is a group of vascular diseases with different pathological backgrounds. The higher vasculature network of the blood vessel is usually affected by arterioles, arterioles, capillaries and venules. There are several categories of cerebral small vessel diseases including Binswanger’s disease, leukoaraiosis, cerebral microbleeds (CMBs) and lacunar stroke, is mainly manifested as cognitive decline and emotional disturbance clinically. Small cerebral vas-cular cognitive dysfunction is an important subtype of vascular cognitive dysfunction, and cognitive dysfunction is the most common clinical manifestations of small cerebral vascular disease. The risk factors of cognitive dysfunction induced by small cerebral vascular disease may involve age, gender, obesity and other factors, therefore, the in-depth study of the risk factors of cerebral small vascular disease cognitive dysfunction can further improve and enrich the prevention and treatment of cerebral small vascular disease cognitive dysfunction, delay the disease progression, improve the quality of life.
文章引用:宋芳星, 韩士军, 王婧彬, 周慧敏, 闫中瑞. 脑小血管病性认知功能障碍的危险因素研究进展[J]. 临床医学进展, 2022, 12(12): 11263-11268. https://doi.org/10.12677/ACM.2022.12121623

参考文献

[1] Li, Q., Yang, Y., Reis, C., et al. (2018) Cerebral Small Vessel Disease. Cell Transplantation, 27, 1711-1722. [Google Scholar] [CrossRef] [PubMed]
[2] Cuadrado-Godia, E., Dwivedi, P., Sharma, S., et al. (2018) Cer-ebral Small Vessel Disease: A Review Focusing on Pathophysiology, Biomarkers, and Machine Learning Strategies. Journal of Stroke, 20, 302-320. [Google Scholar] [CrossRef] [PubMed]
[3] Wardlaw, J.M., Smith, C. and Dichgans, M. (2019) Small Vessel Disease: Mechanisms and Clinical Implications. The Lancet Neurology, 18, 684-696. [Google Scholar] [CrossRef
[4] Scott, T.M., Bhadelia, R.A., Qiu, W.Q., et al. (2018) Small Vessel Cerebrovascular Pathology Identified by Magnetic Resonance Imaging Is Prevalent in Alzheimer’s Disease and Mild Cognitive Impairment: A Potential Target for Intervention. Journal of Alzheimer’s Disease, 65, 293-302. [Google Scholar] [CrossRef
[5] Szcześniak, D., Rymaszewska, J., Zimny, A., et al. (2021) Cerebral Small Vessel Disease and Other Influential Factors of Cognitive Impairment in the Middle-Aged: A Long-Term Ob-servational Cohort PURE-MIND Study in Poland. GeroScience, 43, 279-295. [Google Scholar] [CrossRef] [PubMed]
[6] Das, A.S., Regenhardt, R.W., Vernooij, M.W., et al. (2019) Asymptomatic Cerebral Small Vessel Disease: Insights from Population-Based Studies. Journal of Stroke, 21, 121-138. [Google Scholar] [CrossRef] [PubMed]
[7] Levit, A., Hachinski, V. and Whitehead, S.N. (2020) Neurovascular Unit Dysregulation, White Matter Disease, and Executive Dysfunction: The Shared Triad of Vascular Cognitive Im-pairment and Alzheimer Disease. GeroScience, 42, 445-465. [Google Scholar] [CrossRef] [PubMed]
[8] Carey, C.L., Kramer, J.H., Josephson, S.A., et al. (2008) Sub-cortical Lacunes Are Associated with Executive Dysfunction in Cognitively Normal Elderly. Stroke, 39, 397-402. [Google Scholar] [CrossRef
[9] Rensma, S.P., van Sloten, T.T., Launer, L.J., et al. (2018) Cerebral Small Vessel Disease and Risk of Incident Stroke, Dementia and Depression, and All-Cause Mortality: A Systematic Review and Meta-Analysis. Neuroscience & Biobehavioral Reviews, 90, 164-173. [Google Scholar] [CrossRef] [PubMed]
[10] Ungvari, Z., Tarantini, S., Kirkpatrick, A.C., et al. (2017) Cerebral Microhemorrhages: Mechanisms, Consequences, and Prevention. American Journal of Physiology-Heart and Circulatory Physiology, 312, H1128-H1143. [Google Scholar] [CrossRef] [PubMed]
[11] Lee, J.H., Kim, Y.J., Moon, Y., et al. (2012) Acute Simultaneous Multiple Lacunar Infarcts: A Severe Disease Entity in Small Artery Disease. European Neurology, 67, 303-311. [Google Scholar] [CrossRef] [PubMed]
[12] Li, R. and Singh, M. (2014) Sex Differences in Cognitive Impairment and Alzheimer’s Disease. Frontiers in Neuroendocrinology, 35, 385-403. [Google Scholar] [CrossRef] [PubMed]
[13] Austin, M.P., Mitchell, P. and Goodwin, G.M. (2001) Cognitive Deficits in Depression: Possible Implications for Functional Neuropathology. The British Journal of Psychiatry, 178, 200-206. [Google Scholar] [CrossRef] [PubMed]
[14] Parfenov, V.A., Ostroumova, O.D., Ostroumova, T.M., et al. (2019) Vascular Cognitive Impairment: Pathophysiological Mechanisms, Insights into Structural Basis, and Perspectives in Specific Treatments. Neuropsychiatric Disease and Treatment, 15, 1381-1402. [Google Scholar] [CrossRef
[15] Liu, Y., Dong, Y.H., Lyu, P.Y., et al. (2018) Hypertension-Induced Cerebral Small Vessel Disease Leading to Cognitive Impairment. Chinese Medical Journal (England), 131, 615-619. [Google Scholar] [CrossRef] [PubMed]
[16] Jiménez-Balado, J., Riba-Llena, I., Abril, O., et al. (2019) Cogni-tive Impact of Cerebral Small Vessel Disease Changes in Patients with Hypertension. Hypertension, 73, 342-349. [Google Scholar] [CrossRef
[17] Akinyemi, R.O., Owolabi, M.O., Ihara, M., et al. (2019) Stroke, Cerebrovascular Diseases and Vascular Cognitive Impairment in Africa. Brain Research Bulletin, 145, 97-108. [Google Scholar] [CrossRef] [PubMed]
[18] Kwon, H., Park, J., Park, J.H., et al. (2016) Vis-ceral Fat Is an Independent Predictor of Cerebral Microbleeds in Neurologically Healthy People. Cerebrovascular Diseases, 42, 90-96. [Google Scholar] [CrossRef] [PubMed]
[19] Tappia, P.S. and Blewett, H. (2020) Nutrition and Cardiovascular Health. International Journal of Molecular Sciences, 21, 2284. [Google Scholar] [CrossRef] [PubMed]
[20] O’Brien, P.D., Hinder, L.M., Callaghan, B.C., et al. (2017) Neurolog-ical Consequences of Obesity. The Lancet Neurology, 16, 465-477. [Google Scholar] [CrossRef
[21] Siervo, M., Arnold, R., Wells, J.C.K., et al. (2011) Inten-tional Weight Loss in Overweight and Obese Individuals and Cognitive Function: A Systematic Review and Me-ta-Analysis. Obesity Reviews, 12, 968-983. [Google Scholar] [CrossRef
[22] McCrimmon, R.J., Ryan, C.M. and Frier, B.M. (2012) Diabetes and Cognitive Dysfunction. The Lancet, 379, 2291-2299. [Google Scholar] [CrossRef
[23] Cao, L., Guo, Y. and Zhu, Z. (2021) Effects of Hyperhomocysteinemia on Ischemic Cerebral Small Vessel Disease and Analysis of Inflammatory Mechanisms. In-ternational Journal of Neuroscience, 131, 362-369. [Google Scholar] [CrossRef] [PubMed]
[24] Smith, A.D. (2008) The Worldwide Challenge of the De-mentias: A Role for B Vitamins and Homocysteine? Food and Nutrition Bulletin, 29, S143-S172. [Google Scholar] [CrossRef
[25] Clarke, R., Smith, A.D., Jobst, K.A., et al. (1998) Folate, Vitamin B12, and Serum Total Homocysteine Levels in Confirmed Alzheimer Disease. Archives of Neurology, 55, 1449-1455. [Google Scholar] [CrossRef] [PubMed]
[26] Oulhaj, A., Refsum, H., Beaumont, H., et al. (2010) Homocysteine as a Predictor of Cognitive Decline in Alzheimer’s Disease. International Journal of Geriatric Psychiatry, 25, 82-90.
[27] Beydoun, M.A., Beydoun, H.A., Gamaldo, A.A., et al. (2014) Epidemiologic Studies of Modifiable Factors Associated with Cognition and Dementia: Systematic Review and Meta-Analysis. BMC Public Health, 14, Article No. 643. [Google Scholar] [CrossRef] [PubMed]
[28] Hankey, G.J., Eikelboom, J.W. (1999) Homocysteine and Vascular Disease. The Lancet, 354, 407-413. [Google Scholar] [CrossRef
[29] Miwa, K., Tanaka, M., Okazaki, S., et al. (2016) Increased Total Homocysteine Levels Predict the Risk of Incident Dementia Independent of Cerebral Small-Vessel Diseases and Vascular Risk Factors. Journal of Alzheimer’s Disease, 49, 503-513. [Google Scholar] [CrossRef
[30] Piao, X., Wu, G., Yang, P., et al. (2018) Association between Homocysteine and Cerebral Small Vessel Disease: A Meta-Analysis. Journal of Stroke and Cerebrovascular Diseases, 27, 2423-2430. [Google Scholar] [CrossRef] [PubMed]
[31] Hainsworth, A.H., Yeo, N.E., Weekman, E.M., et al. (2016) Homocysteine, Hyperhomocysteinemia and Vascular Contributions to Cognitive Impairment and Dementia (VCID). Biochimica et Biophysica Acta (BBA)—Molecular Basis of Disease, 1862, 1008-1017. [Google Scholar] [CrossRef] [PubMed]
[32] Hackshaw, A., Morris, J.K., Boniface, S., et al. (2018) Low Cigarette Consumption and Risk of Coronary Heart Disease and Stroke: Meta-Analysis of 141 Cohort Studies in 55 Study Reports. BMJ, 360, j5855. [Google Scholar] [CrossRef] [PubMed]
[33] Wolf, P.A., D’agostino, R.B., Belanger, A.J., et al. (1991) Probability of Stroke: A Risk Profile from the Framingham Study. Stroke (1970), 22, 312-318. [Google Scholar] [CrossRef
[34] Livingston, G., Sommerlad, A., Orgeta, V., et al. (2017) Dementia Prevention, Intervention, and Care. The Lancet, 390, 2673-2734. [Google Scholar] [CrossRef
[35] Wallace, R. (2016) Session 406—Cognitive Aging: Progress in Understanding and Opportunities for Action. The American Journal of Geriatric Psychiatry, 24, S33. [Google Scholar] [CrossRef
[36] Cataldo, J.K. and Glantz, S.A. (2010) Smoking Cessation and Alzheimer’s Disease: Facts, Fallacies and Promise. Expert Review of Neurotherapeutics, 10, 629-631. [Google Scholar] [CrossRef] [PubMed]
[37] 刘扬, 陈伟红, 李睿, 等. 高血压引起脑小血管病可致认知障碍[J]. 中风与神经疾病杂志, 2018, 35(1): 94-96.
[38] 王多浩, 林兴建, 祝东林, 等. 脑小血管病与认知功能障碍研究进展[J]. 临床神经病学杂志, 2019, 32(3): 237-240.